Discovery Capital Management, LLC Novavax Inc Transaction History

Discovery Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $645,888 - $1.05 Million	-4,800 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $57.9 Million - $88.1 Million	-325,741 Reduced 98.55%	4,800 $995,000
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $849,904 - $1.81 Million	7,024 Added 2.17%	330,541 $70.2 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $19.2 Million - $54.4 Million	-170,133 Reduced 34.46%	323,517 $58.7 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $15.5 Million - $27.4 Million	196,250 Added 65.99%	493,650 $55 Million
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $16.2 Million - $36.5 Million	204,400 Added 219.78%	297,400 $32.2 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $1.29 Million - $7.78 Million	93,000 New	93,000 $7.75 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Discovery Capital Management, LLC , based on Form 13F filings with the SEC.

Stay updated on Discovery Capital Management, LLC with notifications on news.